Back to search

Article

APOE-specific Cognitive Effects of Levetiracetam in Mid-Age Adults

2026-05-21

Abstract excerpt

<h4>Background</h4> Low-dose levetiracetam is under investigation as a potential treatment for slowing Alzheimer’s Disease progression. This study tests whether levetiracetam enhances executive function in mid-age adults, and whether drug effects differ by Apolipoprotein e4 (APOE4+) genetic risk status. <h4>Methods</h4> Fifty-eight adults (aged 45-65 years; 27 APOE33; 31 APOE4+) participated in a double-blind, p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f4f44246-bbcc-501b-a5f6-3ba6ade13b12
DOI
10.64898/2026.05.14.26352135
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
APOE-specific Cognitive Effects of Levetiracetam in Mid-Age AdultsDOI 10.64898/2026.05.14.26352135
Select a neighboring publication to make it the new centre.